Consolidated Statements of Cash Flows - USD ($) $ in Millions		3 Months Ended						9 Months Ended				12 Months Ended
		Sep. 30, 2025		Mar. 31, 2025	Sep. 30, 2024		Mar. 31, 2024	Sep. 30, 2025		Sep. 30, 2024		Dec. 31, 2024
Net income (loss)		$ (318)		$ 656	$ (521)		$ 423	$ 1,654		$ 958
(Income) loss from discontinued operations after income taxes		10			2			87		(45)
Depreciation and Amortization								897		925
Provision for (benefit from) deferred income tax								(72)		(422)
Net Periodic Pension and OPEB (credits) costs, net								27		121
Pension and OPEB Contributions								(110)		(123)
Net (gain) loss on sales of property, businesses, consolidated companies, and investments								(17)		(17)
Restructuring and asset related charges - net	[1]	30			32			131		199
Other net loss								386		377
Accounts and notes receivable								(1,659)		(1,450)
Inventories								331		1,060
Accounts Payable								123		(518)
Deferred Revenue								(2,824)		(2,974)
Other Assets and Liabilities								105		38
Cash Provided by (Used in) Operating Activities, Continuing Operations								(941)		(1,871)
Cash Provided by (Used in) Operating Activity, Discontinued Operation								(28)		(157)
Cash Provided by (Used in) Operating Activities								(969)		(2,028)
Capital expenditures								(369)		(416)
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested								26		2
Investments in and loans to nonconsolidated affiliates								(7)		(7)
Purchases of investments								0		(137)
Proceeds from Sale and Maturities of Investments								68		115
Proceeds from (payments for) settlement of net investment hedge								(56)		15
Other investing activities - net								(17)		(38)
Cash provided by (used for) investing activities								(355)		(466)
Net change in borrowings (less than 90 days)								1,119		1,715
Proceeds from debt								1,643		3,047
Payments on Debt								(1,116)		(1,529)
Repurchase of Common Stock								(770)		(757)
Proceeds from Exercise of Stock Options								75		30
Dividends paid to stockholders								(354)		(340)
Other financing activities								(43)		(29)
Cash provided by (used for) financing activities								554		2,137
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash								85		(45)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash								(685)		(402)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period				3,422			3,158	3,422		3,158		$ 3,158
Cash, Cash Equivalents and Restricted Cash at End of Period		2,737	[2]		2,756	[2]		2,737	[2]	2,756	[2]	3,422
EIDP
Net income (loss)		(318)		656	(507)		428	1,654		987
(Income) loss from discontinued operations after income taxes		10			2			87		(45)
Depreciation and Amortization								897		925
Provision for (benefit from) deferred income tax								(72)		(422)
Net Periodic Pension and OPEB (credits) costs, net								27		121
Pension and OPEB Contributions								(110)		(123)
Net (gain) loss on sales of property, businesses, consolidated companies, and investments								(17)		(17)
Restructuring and asset related charges - net		30			32			131		199
Other net loss								386		377
Accounts and notes receivable								(1,659)		(1,450)
Inventories								331		1,060
Accounts Payable								123		(518)
Deferred Revenue								(2,824)		(2,974)
Other Assets and Liabilities								105		(6)
Cash Provided by (Used in) Operating Activities, Continuing Operations								(941)		(1,886)
Cash Provided by (Used in) Operating Activity, Discontinued Operation								(28)		(157)
Cash Provided by (Used in) Operating Activities								(969)		(2,043)
Capital expenditures								(369)		(416)
Net payments from (advances to) Parent on in-house banking arrangement								0		(1,091)
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested								26		2
Investments in and loans to nonconsolidated affiliates								(7)		(7)
Purchases of investments								0		(137)
Proceeds from Sale and Maturities of Investments								68		115
Proceeds from (payments for) settlement of net investment hedge								(56)		15
Other investing activities - net								(17)		(38)
Cash provided by (used for) investing activities								(355)		(1,557)
Net change in borrowings (less than 90 days)								1,119		1,715
Net payments from (advances to) Parent on in-house banking arrangement								129		0
Proceeds from debt								1,643		3,047
Payments on Debt								(1,116)		(1,529)
Proceeds from Exercise of Stock Options								75		30
Other financing activities								(36)		(20)
Cash provided by (used for) financing activities								554		3,243
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash								85		(45)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash								(685)		(402)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period				$ 3,422			$ 3,158	3,422		3,158		3,158
Cash, Cash Equivalents and Restricted Cash at End of Period		2,737			$ 2,756			2,737		2,756		$ 3,422
EIDP | Corteva [Member]
Dividends paid to stockholders		$ (372)						$ (1,260)		$ 0

[1] Includes restructuring plans and asset related charges, as well as accelerated prepaid amortization expense for the three and nine months ended September 30, 2024. See Note 4 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information.

[2] See page 15 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.